Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma, Diffuse
Scleroderma, Systemic
Scleroderma, Limited
Sclerosis, Progressive Systemic
Skin Diseases
Connective Tissue Diseases
Pathologic Processes
Autoimmune Diseases

Interventions

DRUG: Oral Ifetroban
DRUG: Oral Placebo

Sponsor

Cumberland Pharmaceuticals